Substrate specificity of human ribonucleotide reductase from Molt-4F cells
- PMID: 498135
Substrate specificity of human ribonucleotide reductase from Molt-4F cells
Abstract
Nucleoside triphosphates were examined as the activator for various nucleoside diphosphate reductions catalyzed by a highly purified ribonucleotide reductase obtained from Molt-4F cultured human cells. It was found that cytidine 5'-diphosphate and uridine diphosphate reductions are activated by adenosine 5'-triphosphate with apparent Ka's of 0.63 +/- 0.03 (S.E.) and 1.25 +/- 0.10 mM, respectively. Guanosine 5' diphosphate reduction is activated by deoxythymidine 5'-triphosphate with an apparent Ka of 1.25 +/- 0.11 microM, and adenosine 5'-diphosphate reduction is activated by guanosine 5'-triphosphate or deoxyguanosine 5'-triphosphate with an apparent Ka of 1.1 +/- 0.09 or 1.1 +/- 0.08 mM, respectively. In the presence of saturating amounts of their best activating nucleoside triphosphates, the Km's of various nucleotide diphosphates for this purified enzyme were studied. Double reciprocal plots of velocity against substrate concentration were found to be linear for all four substrates in the concentration range tested and yielded apparent Km's of 7 +/- 0.3 microM for cytidine 5'-diphosphate, 80 +/- 6.5 microM for adenosine 5'-diphosphate, 33 +/- 3.1 microM for guanosine 5'-diphosphate, 50 +/- 2.0 microM for uridine 5'-diphosphate. The reduction of one ribonucleoside diphosphate could be inhibited by other ribonucleoside diphosphates in a noncompetitive manner.
Similar articles
-
Effects of nucleoside triphosphates on human ribonucleotide reductase from Molt-4F cells.Cancer Res. 1979 Dec;39(12):5087-92. Cancer Res. 1979. PMID: 498136 No abstract available.
-
Allosteric regulation of calf thymus ribonucleoside diphosphate reductase.Biochemistry. 1979 Jul 10;18(14):2948-52. doi: 10.1021/bi00581a005. Biochemistry. 1979. PMID: 223624 No abstract available.
-
Effects of deoxyadenosine triphosphate and 9-beta-D-arabinofuranosyl-adenine 5'-triphosphate on human ribonucleotide reductase from Molt-4F cells and the concept of "self-potentiation".Cancer Res. 1980 Oct;40(10):3555-8. Cancer Res. 1980. PMID: 6159965
-
Allosteric regulation of calf thymus ribonucleotide reductase.Ciba Found Symp. 1978;(68):165-75. Ciba Found Symp. 1978. PMID: 387355 Review.
-
Nature and properties of mammalian ribonucleoside diphosphate reductase.Pharmacol Ther. 1984;26(2):191-207. doi: 10.1016/0163-7258(84)90016-0. Pharmacol Ther. 1984. PMID: 6398448 Review. No abstract available.
Cited by
-
Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair.World J Gastroenterol. 2012 Sep 14;18(34):4704-13. doi: 10.3748/wjg.v18.i34.4704. World J Gastroenterol. 2012. PMID: 23002339 Free PMC article.
-
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.Clin Exp Metastasis. 1998 Jan;16(1):43-9. doi: 10.1023/a:1006559901771. Clin Exp Metastasis. 1998. PMID: 9502076
-
Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.J Clin Invest. 1986 Nov;78(5):1261-9. doi: 10.1172/JCI112710. J Clin Invest. 1986. PMID: 3490493 Free PMC article.
-
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study.Leuk Lymphoma. 2016 Oct;57(10):2307-14. doi: 10.3109/10428194.2016.1146947. Epub 2016 Feb 19. Leuk Lymphoma. 2016. PMID: 26895565 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources